Object. Ventriculoatrial (VA) shunting is rarely used for patients with normal-pressure hydrocephalus (NPH), likely due to surgeon technical preference and case reports indicating cardiopulmonary complications. However, these complications have typically been limited to adults in whom VA shunts had been placed when they were children. Few studies have directly compared VA shunting to ventriculoperitoneal (VP) shunting in cases of NPH.
T he optimal treatment for normal-pressure hydrocephalus (NPH) has been debated since the first description of the disease by Adams and colleagues in 1965. 1 In the modern era, typical treatment modalities used to achieve CSF diversion include ventriculoperitoneal (VP) and ventriculoatrial (VA) shunt placement and endoscopic third ventriculostomy. At present, VP shunting is the most commonly used intervention. 2 In contrast to VP shunting, VA shunting provides intraoperative confirmation of placement location and a consistent lowpressure outlet. We hypothesized that these characteristics are of high value in the treatment of NPH and will become increasingly important given the global obesity epidemic. 36 Yet VA shunting may be underutilized due to the technical preferences and biases of neurosurgeons, as well as concerns arising from case reports of cardiopulmonary complications. 8, 18, 23, 27, 28, 33, 37 However, most of these complications have been reported in adult patients in whom VA shunts had been placed when they were children for pediatric indications. There are few studies directly comparing the complications of VA and VP shunts, particularly in the NPH population. Thus, we conducted a study to evaluate the safety of VA shunts and to explore whether there may be any advantages to the use of VA shunts over VP shunts for NPH.
Methods

Study Population
The study was approved by the institutional review board of Columbia University Medical Center. A retroShould ventriculoatrial shunting be the procedure of choice for normal-pressure hydrocephalus?
spective chart review was performed for all patients in whom VA and VP shunts were placed by the senior author from January 2002 through December 2011 at our institution. The study population was determined using Current Procedural Terminology codes for VP (62223) and VA (62220) shunt procedures. Patients with both idiopathic and secondary NPH were included. Secondary causes of NPH in the VP shunt cohort included neoplastic (n = 11), aqueductal stenosis (n = 2), cystic (n = 2), posttraumatic (n = 1), and Chiari malformation (n = 1) whereas causes in the VA cohort were limited to neoplastic (n = 2). Ventriculoperitoneal shunts were generally placed as the primary surgical option, with VA shunts reserved for patients with extensive abdominal surgical histories, failed VP shunt surgery, or morbid obesity.
We found a total of 187 patients who underwent 234 shunt-related procedures. Thirty patients received VA shunts and 157 patients received VP shunts, which resulted in 37 and 197 shunt-related procedures for VA and VP groups, respectively. Of the 30 VA shunt-treated patients, VP shunts had previously failed in 10 for the following reasons: abdominal scarring in 3, raised intraabdominal pressure in 4, low-pressure hydrocephalus in 2, and infection in 1. The other 20 patients received primary VA shunts because of prior abdominal surgeries (n = 10) and concern for raised intraabdominal pressure due to body habitus (n = 10). In 1 patient in whom a VP shunt had been converted to a VA shunt, the device was converted back to a VP shunt after it was tied off for treatment of a subdural hematoma at another institution. The patient subsequently required a distal revision for obstruction caused by abdominal scarring.
Surgical Technique: VA Shunt Surgery
Ventriculoatrial shunt surgery was performed with the patient under general anesthesia and in the supine position. The proximal catheter was placed frontally in patients with a good hairline and parietally, using stereotactic guidance, in patients with prominent male-pattern baldness. A cranial opening was drilled and the proximal catheter placed into the lateral ventricle. The programmable shunt valve with attached distal catheter was placed prior to accessing the venous system, with care taken to prime the system with irrigation fluid to avoid the potential of an air embolism.
Subsequently, a board-certified vascular surgeon accessed the ipsilateral internal jugular vein using the Seldinger technique. In all cases, intraoperative ultrasound was used to localize the internal jugular vein of choice, and intraoperative fluoroscopy was used to monitor the Seldinger technique and optimize distal shunt catheter length and final location. After accessing the internal jugular vein, the guidewire was advanced under fluoroscopic guidance into the right atrium. The valve and distal shunt catheter were then tunneled from the proximal shunt incision down to the neck access point. The proximal catheter was attached to the valve and spontaneous CSF flow confirmed through the shunt. The appropriate distal shunt catheter length was then determined by fluoroscopy, such that the catheter terminated just above the right atrium. A sheath dilator was placed into the internal jugular vein, and the VA shunt was cut to the proper length. The dilator was then removed, and the VA shunt was advanced down the sheath through the deep venous system into the superior vena cava under fluoroscopic guidance. The peelaway sheath was cracked and peeled away, leaving the catheter in place. Fluoroscopy at the end of the procedure confirmed appropriate positioning of the catheter.
Outcome Variables
Variables to analyze were determined prior to the study. Demographic variables included the patient's age, sex, and race. Perioperative data included age at operation, type of shunt, type of valve, opening pressure, and complications. Perioperative complications were classified as symptomatic intracerebral hemorrhage, infection, and perioperative seizure. Outcomes data included length of follow-up and postoperative complications. Postoperative complications included radiographically defined subdural hematoma and hygroma, distal catheter revision, proximal catheter revision, abdominal discomfort, hearing loss, and facial weakness.
Statistical Analysis
The chi-square test and Wilcoxon rank-sum test were performed with MATLAB software (MathWorks) for categorical and continuous variables, respectively. Statistical significance was defined as a p value < 0.05. Results are reported ± 1 SD unless otherwise specified.
Results
During the 10-year study period, 30 patients (47% male) underwent 37 VA shunt procedures and 157 patients (55% male, p = 0.34) underwent 197 VP shunt procedures. The average age at time of surgery was 73.7 ± 9.4 years (range 46-87 years) for the VA cohort and 76.0 ± 8.2 years (range 46-91 years) (p = 0.19) for the VP cohort. The median follow-up duration for VA shunt-treated patients was 42.0 months (IQR 19.2-63.6 months) and that for VP shunt-treated patients was 34.2 months (IQR 15.8-67.5 months) (p = 0.75, Table 1 ).
Perioperative Complications
The perioperative complication rates for VA shunting and VP shunting, respectively, were as follows: hemorrhage 0% versus 1.5% (p = 0.44), infection 0% versus 2.0% (p = 0.38), and postoperative seizure 2.7% versus 1.5% (p = 0.61, Table 2 ). The 3 cases of hemorrhage in the VP group were treated conservatively with adjustment of the shunt setting and did not require surgical intervention.
Postoperative Complications
The postoperative complication rates for VA and VP shunting, respectively, included distal catheter revision in 2.7% versus 6.6% (p = 0.36), proximal catheter revision in 2.7% versus 2.5% (p = 0.95), and subdural hematoma/ subdural hygroma in 8.1%/27.0% versus 6.6%/26.4% (p = 0.74/p = 0.94, Table 2 ). In the VA shunt group, 1 patient required evacuation of a subdural hematoma that necessitated conversion to a VP shunt. Two other patients re-quired valve replacements for large subdural hygromas (Table 3 ). In the VP group, 4 patients required evacuation of subdural hematomas, and 1 patient required a valve change for a subdural hygroma. The subdural hematomas and hygromas in all other patients were managed by adjusting the valve. Additionally, VP shunting was associated with several complications not associated with VA shunting, including abdominal discomfort (8.6%), hearing loss (5.6%), and facial weakness (1.5%).
Of note, no patient in the VA group experienced any cardiovascular complication that could be directly attributed to shunt placement, including but not limited to embolism, heart failure, pulmonary hypertension, or infective endocarditis. There were no instances of distal catheter obstruction; the sole distal revision in the VA group occurred in the setting of a subdural hematoma.
Discussion
In the present study, we found no significant difference in perioperative and postoperative complications between VA and VP shunt surgery for patients with NPH. The VA shunt cohort had a lower trend of hemorrhage, infection, distal catheter malfunction, and proximal catheter malfunction that did not reach statistical significance, in part due to the much lower number of VA shunt procedures. While the incidence of radiographically determined subdural hematomas had a slightly higher, nonsignificant, trend in the VA group, the incidence of subdural hygromas was similar. There were no perioperative deaths associated with either VA or VP shunting, and no cardiopulmonary complications were reported for any of the VA patients. As a whole, these results are consistent with other pediatric and adult series in the literature that demonstrate no difference in complication rates between VA and VP shunts when those rates are directly compared. [14] [15] [16] 22, 29, 34 Likewise, the complication and mortality rates were somewhat lower, although largely consistent with previously published findings in series where VA and VP shunt complications were not directly compared. The infection rates in our VP and VA shunt cohorts were lower than those seen in other reports, which range from 2.5% to 18.9% 4, 12, 20, 21, 23, 31, 35 and from 0% to 13%, 3, 5, 13, 19, 20, 30 respectively. Similarly, mortality rates for VP shunt and VA shunt surgery have been documented at 0%-6% 4, 11, 12, 21, 35 and 0%-9%, 3, 12, 15, 20, 25, 34 respectively-rates that are consistent with the present study. There remains a wide variation in complication rates across studies, yet our study suggests that neither VP nor VA shunts have superior safety and efficacy.
Although the complication rates do not differ between VA and VP shunt surgeries, we acknowledge that all complications are not equal in severity. Indeed, alarming case studies have reported that VA shunts may require distal revisions mainly due to hematological complications such as thrombosis formation on the distal catheter, jugular thrombosis, or vena cava thrombosis.
14,20 These obstructions have generated a great deal of concern over the potential for future cardiopulmonary complications in VA shunt-treated patients, which has likely contributed to the relative underutilization of this therapy. However, in our elderly NPH population, distal obstruction and cardiopulmonary complications were not observed. This may be due to advances in surgical technique, a function of a patient population frequently receiving anticoagulation and/or antiplatelet agents, or the need for longer follow-up. Our results indicate that VA shunting is at least as safe as VP shunting for NPH. Given these findings, we sought to identify why VA shunts have become less common in the treatment of NPH and whether this treatment option may hold any advantages over VP shunting.
Prior to the use of silicon tubing for VP shunts in the 1960s, a VA shunt was the preferred device for the treatment for hydrocephalus because obstruction in the peritoneal cavity was common when using a polyethylene catheter. 17 Data from that period directly comparing the two shunt types were presented by several groups in the 1970s. 14, 15, 34 In each case, no statistically significant difference was found between proximal or distal revision rates or infections. In a large study of 300 patients in whom shunts were placed for various etiologies (114 VP, 177 VA, and 9 other shunts) and who ranged in age from 1 day to 90 years, Ignelzi and Kirsch found that a very high proportion (55%) of the VA revisions were due to distal occlusion of the catheter. 14 In retrospect, this finding is likely a function of the absence of accurate and readily available intraoperative imaging at the time that would have aided in optimum placement. Additionally, infection rates were much higher during that period (13% for VA shunts vs 10.6% for VP shunts), 14 which greatly affected mortality rates (7%-9% for VA shunts). 15, 34 These results led the authors to conclude that although the complication rates were similar in the two groups, the potential for harm was greater in the VA group.
Since the transition to VP shunting in the 1970s, few studies have reported additional comparisons of VA and VP shunts in the adult population. Studies comparing VA to VP shunting in the pediatric population by Little et al., Olsen and Frykberg, and Keucher and Mealey in the 1970s and 1980s showed that VA shunts required more revisions due to the growth of the child, had similar complications rates, and were associated with a higher mortality rate than VP shunts. 16, 22, 29 It is important to note that during this period, the sparse evidence of VA shunt inferiority-and the associated reports of cardiopulmonary complications-relied on research collected from the pediatric population.
In 1995, Lam and Villemure were the first to directly compare VA and VP shunts in adult hydrocephalus patients. Of 128 patients, 52 were treated with a VA shunt and 76 were treated with VP shunts in a study whose follow-up ranged from 2 months to 8 years. Revision rates were 27.1% for VA shunts and 25.6% for VP shunts. In the VA shunt group, 31% of revisions were due to distal blockage and 19% were due to proximal malfunction. There was a higher rate of distal obstruction in the VA shunt group than the VP shunt group (4 of [6.8%] 59 vs 5 of [4.6%] 109). 20 However, in this adult-only cohort, 20 the VA shunt distal obstruction rate was significantly lower than the 44.8% reported in a mixed pediatric/adult cohort.
14 No serious cardiopulmonary complications were reported.
20
Other factors have obscured the study of the cardiopulmonary complications associated with VA shunts in the adult population. Much of the literature analyzing the peri-and postoperative complication rates of VA shunts reporting distal obstruction rates differ in follow-up duration from those describing adverse cardiopulmonary events. The documented latency period before the development of adverse cardiopulmonary events is typically 10-20 years after surgery. 23 It is not surprising that the few series that have reported these adverse cardiopulmonary events in adults are studies that investigated long-term outcome in shunts implanted for pediatric indications. 18, 23 Our study demonstrates that VA shunts are a safe option in the treatment of NPH. Currently, VA shunts are primarily used in our practice for NPH patients with a history of abdominal surgery, a history of VP shunt infection, or increased intraabdominal pressure due to obesity. These are all patient groups in which VP shunting is potentially a poor option for the management of NPH, with a higher risk of shunt failure or need for revision. Ventriculoatrial shunting in these NPH subgroups is at least as safe and effective as VP shunting is in adult hydrocephalus patients who do not have these negative risk factors.
The common difficulties that have caused VA shunting to lose favor in recent years are less likely to affect the NPH population. Compared with pediatric patients, adults are not at risk for "outgrowing" their VA shunts and needing elective revisions to lengthen or move their distal shunts. In addition, elderly NPH patients will not have a VA shunt for the same extended time period as pediatric patients-the population in which a majority of cardiopulmonary complications are reported. Furthermore, in contrast to younger patient groups, elderly NPH patients may have a lower risk of developing distal thrombi that could cause cardiopulmonary complications since they often use anticoagulation or antiplatelet therapy for comorbid conditions. In our VA shunt cohort, approximately 50% of the patients took aspirin daily, which potentially aided in preventing distal obstructions.
Aside from age-related factors, technical surgical differences also underscore the potential usefulness of VA shunting. The placement of a VA shunt using the Seldinger technique is a simple and safe surgery. It is facilitated by being able to directly visualize, in real time, the distal location of the catheter under fluoroscopic guidance to ensure appropriate positioning. Thus, the surgeon can immediately identify whether a catheter is malpositioned. In the placement of VP shunts, however, the distal tip of the catheter is placed under direct visualization, but its positioning in the peritoneum can only be confirmed radiographically after surgery. 10 It has been proposed that the use of intraoperative fluoroscopy during VA shunt placement also may decrease distal tip occlusion by ensuring proper placement in the atrium instead of the superior vena cava or subclavian vein, locations that have been shown to reduce flow and promote thrombus formation.
9,32 However, we deliberately place our VA shunts in the subclavian vein just above the atrium because of concerns over possible atrial arrhythmias in the elderly NPH population. We have not had any problems with symptomatic distal occlusion at this location.
By terminating just above the atrium, a VA shunt is likely to have a low-pressure outlet for drainage. In contrast, there is a great deal of variation in intraabdominal pressures depending on position. Normal intraabdominal pressure has traditionally been measured at 5-7 mm Hg when the individual is supine, but it has been found to be increased in obese patients to 9-14 mm Hg, with an increase in 4 mm Hg and 9 mm Hg for head elevations to 30° and 45°, respectively. 7 In another study with healthy, young adults, the mean intraabdominal pressures for sitting and standing were 16.7 mm Hg and 20 mm Hg, and these pressures increased as body mass index increased. 6 Despite the elevated central venous pressure that can occur in obese patients, we did not find any patients in whom VA shunts underdrained at low-pressure valve settings, a problem encountered multiple times in obese patients with VP shunts. Given the trend toward obesity, VA shunts may prove to be more effective in this patient population since often times the intracranial pressure may be the same, if not lower, than the intraabdominal pressure.
Study Limitations and Future Directions
Although we have found that VA shunting is as safe as VP shunting for elderly patients, there are limitations to this study. It is retrospective in nature, and the patient population is drawn from a tertiary referral and academic medical center. Because VA shunts were placed in obese patients or patients with a history of complicated prior abdominal surgeries, there was clear selection bias by the senior surgeon. However, these patients are inherently more likely to experience poor outcomes after VP shunt placement. Patients with a history of abdominal surgery are at higher risk for distal obstructions from scarring, while obese patients are at higher risk for surgical complications overall. Thus, we would predict higher complication rates in this surgically difficult cohort than in a healthier subset of the NPH population.
Additionally, our VA shunt procedure relies on collaborative efforts between the senior author and the vascular surgery department, which may affect our complication rates. When placing VA shunts, we use both intraoperative fluoroscopy and ultrasound to ensure proper positioning of the distal catheter. Similarly, others advocate the use of transesophageal or transthoracic echocardiography monitoring during VA shunt placement. 24, 26 The advantages of ultrasound technology in this setting include ease of use for the surgeon and a reduction of radiation exposure for the patient. One must balance the cost and effort of coordinating a vascular surgeon and intraoperative imaging with the potential benefits of VA shunt surgery. However, the average operating room time for the vascular surgeon is less than 30 minutes and in individual cases is often less than 15 minutes. The fluoroscopy is run by the surgical team and does not generate increased expense. In institutions in which this coordination may not be possible, neurosurgeons adopting the procedure may experience a learning curve, potentially affecting outcomes. We examined our own experience by dividing the 10-year study period into quartiles and evaluating whether one quartile had a higher complication rate than any other. We found no evidence of a learning curve, although we have used an experienced vascular surgeon since we started placing VA shunts for NPH. In the future, a prospective study comparing VA and VP shunts would more robustly differentiate between the safety and efficacy of these two procedures.
Conclusions
In our study, we found that VA shunt surgery was at least as safe as VP shunt surgery for patients with NPH. Compared with the 1970s, when the first comparisons between VA and VP shunts were reported, infection control has improved, imaging has become more widely available, and many elderly patients are receiving pharmacological therapy to prevent the formation of distal thrombi. These factors facilitate the serious reconsideration of the primary use of VA shunting for some NPH patients. We believe that VA shunts have distinct advantages that make them an excellent treatment option for NPH, because this population may be at greater risk for VP shunt complications as the population becomes more obese.
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